Background material for the development of the Food and Drug Administration's recommendations on thyroid-blocking with potassium iodide

LDR 01832cam a2200445 a 4500
001 102336605
003 MiAaHDL
005 20180416000000.0
006 m d
007 cr bn ---auaua
008 810611s1981 mdua b f000 0 eng d
035 ⊔ ⊔ ‡asdr-ucsd.b28168513
035 ⊔ ⊔ ‡asdr-ucbk.b121709759
040 ⊔ ⊔ ‡aGPO ‡cGPO ‡dOCoLC ‡dUtOrBLW
074 ⊔ ⊔ ‡a498-B-2
086 0 ⊔ ‡aHE 20.4102:T 42
099 ⊔ 2 ‡aHE 20.4102:T 42
035 ⊔ ⊔ ‡a(OCoLC)7510192
245 0 0 ‡aBackground material for the development of the Food and Drug Administration's recommendations on thyroid-blocking with potassium iodide / ‡cby Jerome A. Halperin ... [and others]
260 ⊔ ⊔ ‡aRockville, Md. : ‡bU.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Bureau of Radiological Health ; ‡a[Washington, D.C. : Supt. of Docs., U.S. G.P.O., distributor], ‡c1981
300 ⊔ ⊔ ‡avi, 17 pages : ‡billustrations ; ‡c28 cm
336 ⊔ ⊔ ‡atext ‡btxt ‡2rdacontent
337 ⊔ ⊔ ‡aunmediated ‡bn ‡2rdamedia
338 ⊔ ⊔ ‡avolume ‡bnc ‡2rdacarrier
490 0 ⊔ ‡aHHS publication ; ‡vFDA 81-8158
500 ⊔ ⊔ ‡a"Bureau of Drugs."
504 ⊔ ⊔ ‡aIncludes bibliographical references
538 ⊔ ⊔ ‡aMode of access: Internet.
610 1 0 ‡aUnited States. ‡bFood and Drug Administration
650 ⊔ 0 ‡aRadiation ‡xSafety measures
650 ⊔ 0 ‡aPotassium iodide
650 ⊔ 0 ‡aThyroid gland
700 1 ⊔ ‡aHalperin, Jerome A
710 1 ⊔ ‡aUnited States. ‡bFood and Drug Administration. ‡bBureau of Drugs
710 1 ⊔ ‡aUnited States. ‡bBureau of Radiological Health
CID ⊔ ⊔ ‡a102336605
DAT 0 ⊔ ‡a20150112152209.0 ‡b20180416000000.0
DAT 1 ⊔ ‡a20180417090858.0 ‡b2024-05-01T18:00:02Z
DAT 2 ⊔ ‡a2024-05-01T17:30:02Z
CAT ⊔ ⊔ ‡aSDR-UCSD ‡dIII - MILLENIUM ‡lprepare.pl-004-007
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-ucsd.b28168513 ‡auc1 ‡bSDR ‡cUCSD ‡puc1.31822024355828 ‡sUC ‡1.b28168513
974 ⊔ ⊔ ‡bUC ‡cUCSD ‡d20240501 ‡sgoogle ‡uuc1.31822024355828 ‡y1981 ‡rpd ‡qbib ‡tUS fed doc
974 ⊔ ⊔ ‡bUC ‡cUCBK ‡d20191127 ‡sberkeley ‡uucbk.ark:/28722/h2n29p711 ‡y1981 ‡rpd ‡qbib ‡tUS fed doc